Oleg F. Melnikov

Oleg F. Melnikov

Auto-generated profile, based on publicly available information

Oleg F. Melnikov

State Institution “O.S. Kolomiychenko Institute of Otolaryngology of National Academy of Medical Science of Ukraine”; Kyiv, Ukraine

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2021
Verified
Journal Article
Closed access
OBOleksandr D. Bondarchuk
Oleksandr D. Bondarchuk
OMOleg F. Melnikov
Oleg F. Melnikov
МTМarina D. Timchenko
Мarina D. Timchenko
NDNatalia D. Didyk
Natalia D. Didyk
The authors conducted clinical and immunological research on the identification of сytokine factors of inflammation and regeneration in patients with frontal bone trauma (29) and practically healthy donors (11). Factors of inflammation (interleukin-1β, γ-interferon), anti-inflammation and regeneration (interleukin-34 and transforming growth factor – TGF-1β) were determined in the blood serum by ELISA. It was found that the content of the factor of regeneration decreases and the levels of anti-inflammatory cytokines increase in the blood serum of the patients with frontal traumas with frontal sinus damage.

12 March 2020 in OTORHINOLARYNGOLOGY
Verified
Journal Article
Closed access
ABAlexander Yu. Bredun
Alexander Yu. Bredun
OMOleg F. Melnikov
Oleg F. Melnikov
МTМarina D. Timchenko
Мarina D. Timchenko
Introduction: Chronic inflammatory diseases of the upper respiratory tract of both microbial and viral origin occur due to the immune deficiency of systemic and local nature. Among a large number of immunomodulation agents, a special role belongs to plant preparations, which are characterized by relative harmlessness and high efficiency, both in case of systemic and local use and they are often combined with antimicrobial agents, therefore the aim of the study was to investigate their effect on the reactions and condition of lymphoid cells of tonsilswith separate and combined use in vitro. Methods: Cell suspensions were prepared mechanically and adjusted to a concentration of 2 million/ml in medium 199 with additives. Then, Lizak preparation was added to the cells and starch solution was used in control. Imupret and Esberitox preparations were added to the culture with or without Lizak preparation. After cultivation, the levels of proinflammatory cytokine – Interleukin-1β, pro-allergic factor – Interleukin-4, Th-1 – derivative of cytokine – interferon-γ were studied in the supernatant using the «Tsitokin LLC» reagent kits (RF), as well as tissue regeneration factor – transforming growth factor –TGF-1β (Austria). The preparation was prepared from the cell pellet, in which the relative nonviable cell count was determined in a sample with trypan blue using a light microscope (Olympus CX21FS1).The statistical analysis was performed using Student's t-distribution. Results: Plant-derived preparations did not have any effect on cell viability in culture, did not reduce the level of the pro-inflammatory cytokine interleukin-1β and did not stimulate the production of the regeneration factor TGF-1β. At the same time, the combined use of plant-derived preparations and the antibacterial preparation Lizak in cell culture of tonsils was accompanied by an increase in cell viability compared to the use of Lizak preparation separately, the stimulation of the regulatory antiviral factor interferon-γ and an increase in the production of tissue regeneration factor. Conclusion: The immunomodulating properties of the antibacterial preparation Lizak and plant-derived immunomodulator Esberitox significantly differ in the points of application. Both plant-derived preparations stimulated the production of γ-interferon by tonsil cells in the presence of Lizak preparation, the transforming growth factor TGF-1β, the viability of tonsil cells was the highest with the combination of Lizak and Esberitox.

19 January 2021 in OTORHINOLARYNGOLOGY
Verified
Journal Article
Closed access
OMOleg F. Melnikov
Oleg F. Melnikov
DZDmitry I. Zabolotny
Dmitry I. Zabolotny
DZDiana D. Zabolotna
Diana D. Zabolotna
ABAlexander Yu. Bredun
Alexander Yu. Bredun
OROksana G. Rylska
Oksana G. Rylska
IFInna V. Faraon
Inna V. Faraon
Topicality: It is considered proven that the state of the immune system determines the development and course of many pathological processes, which are based on inflammation. At the same time, taking into account modern trends in assessing the immunological status, a mandatory component is to determine the state of local immunity in the upper respiratory tract. Aim: to conduct an integral analysis of data to determine the state of local immunity in inflammatory diseases of the upper respiratory tract (URT) to select the optimal necessary informative indicators. Materials and methods: A generalization of the data of immunological studies of 168 people with inflammatory pathology of the upper respiratory tract (VDS) was carried out, of whom 42 had chronic tonsillitis (CT), 36 – chronic rhinitis (HR – catarrhal form), 40 – chronic pharyngitis (CP), 28 – secretory mean otitis media (CO), 22 people made up the control group (C) of practically healthy donors. The age of the surveyed was from 14 to 60 years, the duration of the diseases was from 1 to 5 years, female patients predominated (~ 60%). The examination was carried out at the stage of clinical remission. The material for the research was mixed saliva, in which the content of immunolobulins and citrokines was investigated by the ELISA method: enzyme immunoassay, the following factors of immunity and inflammation in the CGS were determined: - secretory and monomeric form of immunoglobulin A (Hema Medica, RF); - immunoglobulins of classes G, M (Hema Medica, RF); - interleukins – 1β; 4; 8; 10 (Cytokine, RF); - interferons α and γ (Cytokine, RF); - pro- and defensins (Nucalt bioteknology, Netherlands); - macrophage inflammatory protein-Mip-1b (Assauro, USA); - salivary lysozyme (Diagnostik Nord, Germany). Statistical processing was carried out using the methods of Student’s t-criterion and angular transformation “φ” according to Fisher. Results: Integral of all methods for determining various types of immunity in diseases of the upper respiratory tract with a chronic course is the insufficiency of factors of both innate and acquired immunity, especially during the period of clinical remission of the disease. A special role in protective reactions belongs to the humoral component, in which the most stable indicator is the level of class A secretory immunoglobulin; it has been shown that almost all the studied components of the immune response had abnormalities in the presence of a chronic inflammatory process in the upper respiratory tract and they can be presented as a line the degree of decrease in the frequency of deviations: secretory IgA, IgG., pro-inflammatory cytokines (IL1β and IL-8), γ-interferon, lysozyme, defensin-β, Mip-1b. Conclusion: The developed criteria and approaches to assessing systemic immunity in patients with inflammatory diseases of the upper respiratory tract can be used in examining patients and assessing the effectiveness of therapy.

31 October 2022 in OTORHINOLARYNGOLOGY
Verified
Journal Article
Closed access
OMOleg F. Melnikov
Oleg F. Melnikov
DZDmitry I. Zabolotnyi
Dmitry I. Zabolotnyi
MSMarina B. Sambur
Marina B. Sambur
DZDiana D. Zabolotna
Diana D. Zabolotna
МTМarina D. Timchenko
Мarina D. Timchenko
TZTetiana A. Zayets
Tetiana A. Zayets
Topicality: Acute respiratory diseases of the upper respiratory tract, which in the vast majority of cases are caused by viruses, especially with frequent recurrences of diseases, reduce local and system immunity, which often leads to the accumulation of bacterial infection due to the activation of endogenous microflora or exogenous infection and causes the development of viral-bacterial diseases. Recurrent respiratory diseases contribute to the formation of chronic pathology of the oro- and nasopharynx, which in turn supports the violation of the body's protective mechanisms. Previous studies have shown that the tonsils of the lymphadenoid pharyngeal ring perform the function of immunological protection, and the absence of palatine tonsils (PT) negatively affects the state of both local and system immunity. Aim: to determine the role of the palatine tonsils in the realization of local humoral reactions in patients with chronic inflammatory diseases of nose and paranasal sinuses when infected with viruses of the respiratory group. Materials and methods: Studies were conducted in 134 patients with chronic inflammatory diseases (CID) of nose and paranasal sinuses (PNS) in remission, among whom 93 had a diagnosis of chronic rhinosinusitis, 27 – chronic catarrhal rhinitis, 14 – allergic rhinitis with chronic bronchitis. The control group consisted of 47 practically healthy persons without pathology from the ENT organs. The examined persons were divided into those who had PT and those from whom they were surgically removed no earlier than five years ago. All examinees were divided into those who had anamnestic antibodies in their blood to one or more of the respiratory viruses, such as: adenovirus, respiratory syncytial virus and influenza A virus in a clinically significant titer, and those in whom antibodies were not detected. The local humoral immunity state of patients was assessed by the content of immune complexes (IC) and concentrations of secretory immunoglobulin A (sIgA), interferons alpha- (α-IFN) and gamma- (γ-IFN) in the oropharyngeal secretion (OS), which were determined by the immunoenzymatic method using sets of reagents for enzyme-linked immunosorbent assays ("Cytokin", RF) and the Stat Fax-2100 analyzer (USA). All examined patients had a healthy state of the oral cavity. Results: The presence or absence of palatine tonsils changes the levels of number of humoral factors of local immunity in oropharyngeal secretion in practically healthy donors and in patients with chronic inflammatory diseases of the nose and PNS. The production of sIgA and α-IFN in OS depends on PM, decreasing in practically healthy persons of the control group who underwent tonsillectomy. Chronic inflammatory diseases of the nose and PNS caused a decrease in the concentration of IC and α-IFN in the OS of patients of both groups- with or without PT. In patients with normal PMs who got sick with viral infections, in contrast to those with removed PMs, α-IFN level in OS increased and practically did not differ from those in healthy donors. The greatest suppression of α-IFN production was determined in patients with CID of the nose and PNS with removed PM and with the absence of clinically significant titers of antiviral antibodies. The level of γ-IFN production did not reliably change in the OS of patients with CID of nose and PNS in the remission phase both with normal PT and after tonsillectomy, but depended to a greater extent on the transferred infectious disease caused by viruses of the respiratory group. Conclusion: PTs play a significant role in the formation of a number of reactions of local immunity in the naso- and oropharynx, both in practically healthy individuals and in patients with chronic inflammatory disease of nose and paranasal sinuses. Therefore, the determination of local immunity indices in patients with chronic inflammatory diseases of the upper respiratory tract with different status of the palatine tonsils, who are in contact or had contact with respiratory viruses, provides an opportunity to identify the most vulnerable links in the system of their anti-infective protection, which should first of all be paid attention to during examination and treatment of patients with chronic inflammatory diseases of the upper respiratory tract, especially in cases of frequent recurrence of acute respiratory diseases.

31 July 2023 in Acta medica Lituanica
Verified
Journal Article
Open access
VPVirych Pavlo
Virych Pavlo
NSNadiia Shuvalova
Nadiia Shuvalova
AKAnton Karas
Anton Karas
GKGalina Karas
Galina Karas
SCSvitlana Chaika
Svitlana Chaika
YMYurii Minin
Yurii Minin
Background . The restoration of auricular cartilage is a major problem of otolaryngology. The low regenerative capacity of cartilage requires alternative approaches such as cell and tissue engineering. Stem cells are one of the ways to repair auricular cartilage damages. The aim of the investigation was the regeneration of an artificial defect of the auricular cartilage of rabbits after the intravenous injection of stem cells. Materials and Methods . The study was carried out on rabbits. A narrow strip of auricular cartilage was surgically removed. A previously prepared suspension of homologous mesenchymal stem cells (5 million) in 0.5 ml physiological solution was injected into the vein of the opposite ear. Tissue samples from the site of the injury were collected after 1, 2, and 3 months. Histological examinations of the tissues were carried out after staining with fuchsin-eosin, azure II-eosin, and according to Weigert. In addition, the amount of interleukin-6 (IL -6) and the transforming growth factor (31 (TGF-(31) in the blood serum were determined. Results . The main method of healing is the formation of a connective tissue scar. Yret, an increase of the number of fibroblasts and single islands of the newly formed auricular cartilage was found, which indicates the migration of the injected stem cells to the site of the damage and settling there. The intravenous injection of stem cells did not affect the secretion of pro -inflammatory IL -6, but significantly increased the amount of TGF-(31. Conclusions . We assume that regenerative processes were stimulated. Nevertheless, they were aimed at quickly restoring the tissue integrity through the typical stages of scar formation. The restoration of cartilage integrity requires additional regulatory factors which will determine the chondrogenic differentiation of stem cells.

10 April 2023 in OTORHINOLARYNGOLOGY
Verified
Journal Article
Closed access
DZDmitry I. Zabolotnyi
Dmitry I. Zabolotnyi
OMOleg F. Melnikov
Oleg F. Melnikov
DZDiana D. Zabolotna
Diana D. Zabolotna
OROksana G. Rylska
Oksana G. Rylska
TSTetyana V. Smagina
Tetyana V. Smagina
МTМarina D. Timchenko
Мarina D. Timchenko
The purpose of the study: to determine the features of the clinical course of the chronic inflammatory diseases of the upper respiratory tract and the basic parameters of immunity in various variants of contact of patients with the coronavirus. Material and methods: The clinical study was conducted during the end of 2021 and 2022. We examined 45 patients with chronic obstructive pulmonary disease, taking into account the transferred COVID-19 and vaccination against it. Among them, 15 patients did not suffer from COVID-19 and were not vaccinated against it (group I), 15 people with chronic inflammatory diseases of the upper respiratory tract, who did not suffer from COVID-19 and were vaccinated against it (Group II), 15 patients with chronic inflammatory diseases of the upper respiratory tract, who were sick with COVID 19 and were vaccinated against it (III gr.). All patients were divided into groups depending on the number of acute viral infections per year: 1-2 times per year, 3-4 times per year, 5-6 times per year, and by the number of episodes of exacerbations of chronic inflammatory diseases of the upper respiratory tract per year (1-2, 3-4, 5 times or more). An immunological study of the following groups of patients was also carried out: I – patients with chronic inflammatory diseases of the upper respiratory tract, who did not suffer from COVID-19 and were not vaccinated against it (n=7); ІІ – patients with chronic inflammatory diseases of the upper respiratory tract, who did not suffer from COVID 19 and were vaccinated against it (n=12); ІІІ – pat ients with chronic inflammatory diseases of the upper respiratory tract, who were sick with COVID 19 and were vaccinated against it (n=15) and a control group (n=32) – clinically healthy individuals who were examined before the very beginning of the COVID-19 epidemic. The relative number of leukocytes, monocytes and lymphocytes in the peripheral blood, the relative number of lymphocytes with markers CD3+, CD8+, CD20+ and immunoglobulins of the IgM, IgG, IgA classes were determined from the basic parameters of immunity. Results: In patients with chronic inflammatory diseases of the upper respiratory tract in the remission stage, the main symptoms of their disease were observed, but they were significantly more pronounced in patients who suffered from Covid-19 and were vaccinated against it. As a result of the comparison of clinical groups of patients, it was established that the frequency of acute respiratory viral infections was higher among those who were sick with Covid-19 and were vaccinated against it. In patients with chronic inflammatory diseases of the upper respiratory tract who had contact with a coronavirus infection, trends to a decrease in the number of blood lymphocytes, CD3+and CD8+ T-lymphocytes and an increase in the concentration of class M immunoglobulin were determined in patients with chronic inflammatory diseases of the upper respiratory tract who had contact with a coronavirus infection and were vaccinated against it. Thus, corona virus infection, especially in combination with vaccination, can negatively affect the state of the basic parameters of immunity.